What if we could replace the brain cells lost in Parkinson’s disease?
In this episode, Professor Roger Barker of the University of Cambridge explains how cutting-edge stem cell research could help restore dopamine function in the brain, and what early human trials are revealing about this promising approach. We explore why Parkinson’s is so difficult to treat, whether exercise can make a meaningful difference, and how researchers are working towards therapies that go beyond managing symptoms to repair the brain itself. We also discuss the limits of current treatments, the potential of stem cell transplantation, and the big question: Could we one day stop Parkinson’s in its tracks?
It’s a fascinating conversation about the future of neuroscience, what we’re learning from clinical trials, and how close we might be to a fundamentally different way of treating Parkinson’s disease.
In this episode - Parkinson’s and dopamine: What happens in the brain, why symptoms emerge, and how dopamine-based treatments work. - Why progress has been difficult: The challenges of studying the living human brain and understanding the different forms of Parkinson’s. - Neuroplasticity and compensation: How the brain adapts to cell loss—and why compensation has its limits. - Exercise and brain health: What one striking patient story suggests about exercise, and what researchers still don’t know about its effects on disease progression. - The brain-body connection: The potential roles of the gut, immune system, sleep, diet and social engagement. - AI, smartphones and cognition: Whether modern technology could change how we exercise our brains, and what remains unknown about any connection to Parkinson’s risk. - Stem cell-derived dopamine cells: How researchers turn pluripotent stem cells into dopamine cell precursors for transplantation. - Inside cell transplantation: Why cells are implanted into the striatum, where dopamine normally acts, rather than the area where the cells originally originate. - Early clinical trial findings: What published trials suggest about safety, clinical response and the challenges still to overcome. - Can cell therapy cure Parkinson’s? Which symptoms might improve, which aspects of the disease would remain, and why disease-modifying treatments are still needed.
His research focuses on Parkinson’s disease, understanding its different subtypes, and developing cell-based therapies to replace dopamine-producing cells lost in the condition. He discusses the promise of stem cell-derived dopamine cell transplantation, the lessons emerging from early clinical trials, and the work still needed to make these therapies safer, more effective and widely available. Further resources Professor Barker recommends exploring the International Society for Stem Cell Research (ISSCR) for accessible educational resources on stem cells, Parkinson’s disease and cell-based therapies. He also highlights educational modules developed with Harvard Medical School covering Parkinson’s and emerging treatments. If you enjoyed this conversation, please like the video, subscribe to the channel, and share your thoughts or questions in the comments.
------------------------------------------------------------------------------------------------------------------------
🌈 Exploring the benefits of red and infra light therapy? Our community receive 10% off the FlexBeam from Recharge Health via this link: ⬇️ https://rechargehealthas.sjv.io/DyJ3mn (learn more about the benefits of healing with light in our 'Light as Medicine' Playlist). 🤝 Join the community - by subscribing, you are self-selecting as a health nerd. We like you. We applaud you. You are shaping the future of health information in real time. As a thank you, we pledge to bring you the best we can, where we are, with the tools we have.
","author_name":"Benjamin Hopkins"}